ATC codes:
A04AD12
EMLc
Indication
Nausea or vomiting
ICD11 code:
MG10
INN
Aprepitant
Medicine type
Chemical agent
List type
Complementary
(EML)
(EMLc)
(EMLc)
Formulations
Oral > Liquid:
125 mg powder for oral suspension (in sachet)
Oral > Solid > capsule: 80 mg (EML) ; 125 mg (EML) ; 165 mg (EML)
Oral > Solid > capsule: 80 mg (EML) ; 125 mg (EML) ; 165 mg (EML)
Sex
All
Age
Also recommended for children
Therapeutic alternatives
The recommendation is for this specific medicine
Patent information
Main patents have expired but secondary patents might remain active in some jurisdictions. For more
information on specific patents and license status for developing countries visit www.MedsPal.org
Read more
about patents.
Wikipedia
DrugBank
Summary of evidence and Expert Committee recommendations
Following the review of the age-appropriateness of formulations of essential medicines for children, the Expert Committee recommended the removal from the EMLc of aprepitant capsules (80 mg, 125 mg and 165 mg). These formulations cannot deliver the recommended dose of aprepitant for children aged below 12 years.